Acorah Software Products - Accounts Production 19.4.300 false true false true No description of principal activity 2 December 2024 31 December 2025 31 December 2025 16112036 Dr Simon Lancaster Mrs Coral Lancaster iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16112036 2024-12-01 16112036 2025-12-31 16112036 2024-12-02 2025-12-31 16112036 frs-core:CurrentFinancialInstruments 2025-12-31 16112036 frs-bus:PrivateLimitedCompanyLtd 2024-12-02 2025-12-31 16112036 frs-bus:FilletedAccounts 2024-12-02 2025-12-31 16112036 frs-bus:Micro-entities 2024-12-02 2025-12-31 16112036 frs-bus:AuditExempt-NoAccountantsReport 2024-12-02 2025-12-31 16112036 frs-bus:Director1 2024-12-02 2025-12-31 16112036 frs-bus:CompanySecretary1 2024-12-02 2025-12-31
Registered number: 16112036
Canopy Clinical Support Ltd
Unaudited Financial Statements
For the Period 2 December 2024 to 31 December 2025
Balance Sheet
Registered number: 16112036
31 December 2025
£
Fixed assets 1,339
Current assets 31,240
Creditors: Amounts Falling Due Within One Year (6,810 )
NET CURRENT ASSETS 24,430
TOTAL ASSETS LESS CURRENT LIABILITIES 25,769
Accruals and deferred income (299 )
NET ASSETS 25,470
CAPITAL AND RESERVES 25,470

Notes

1. General Information
Canopy Clinical Support Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16112036 . The registered office is 167-169 Great Portland Street, 5th Floor, London, W1W 5PF.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Simon Lancaster
Director
24th August 2026